Patton Medical Devices
Patton Medical Devices is a company.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at Patton Medical Devices.
Patton Medical Devices is a company.
Key people at Patton Medical Devices.
Key people at Patton Medical Devices.
Patton Medical Devices LP is a medical device company focused on diabetes management, developing innovative injection ports to simplify insulin delivery for patients.[3][4] Founded in 2004 and headquartered in Austin, Texas, it raised $15 million in funding to accelerate the national launch of its flagship product—a wearable "port" that allows diabetics to inject insulin and other medications more easily without repeated needle sticks.[2][4][5] The company serves diabetic patients and healthcare providers, addressing the pain, inconvenience, and compliance challenges of traditional injections, with early momentum from its funding round enabling scaled commercialization.[3][4]
Patton Medical Devices LP was founded on February 25, 2004, by Catherine Patton, who brought expertise to manufacturing medical devices and equipment.[2] The idea emerged from the need to improve diabetes care, leading to the development of a specialized injection port as its first product.[3][4] A pivotal moment came with a $15 million investment, which fueled the national rollout and positioned the company for growth in the competitive medtech space.[4] Headquartered at 3108 N. Lamar Blvd. in Austin, TX, it operated as a focused startup tackling unmet needs in patient-centric diabetes solutions.[5]
(Note: Search results distinguish this from Pattons Medical, a separate entity manufacturing medical gas equipment like air and vacuum systems, founded in 2008 and now under ELGi USA.[1][6] This profile centers on Patton Medical Devices LP based on the query.)
Patton Medical Devices rides the wave of advancing diabetes care amid rising global prevalence—over 500 million cases worldwide—driven by trends in wearable medtech and patient self-management tools.[3] Timing aligns with surging demand for less invasive devices, fueled by market forces like aging populations, obesity epidemics, and post-pandemic telehealth integration, which favor portable solutions over clinic-dependent care. By influencing diabetes ecosystems through easier compliance, it contributes to broader reductions in healthcare costs and complications, paralleling innovations from players like Insulet or Tandem Diabetes.
Patton Medical Devices is poised for expansion in the $100B+ diabetes device market, with potential acquisitions by big pharma or medtech giants given its funded product launch.[3][4] Trends like AI-enhanced wearables, continuous glucose monitoring synergies, and value-based care will shape its path, amplifying influence through partnerships or iterative ports for other injectables. As diabetes tech evolves toward seamlessness, Patton's focus on injection simplicity positions it to redefine daily management, building on its Austin roots to sustain momentum in a high-stakes field.